Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.

Clinics (Sao Paulo, Brazil) - 1 Jan 2012

Bacchi Carlos E, Ciol Heloísa, Queiroga Eduardo M, Benine Lucimara C, Silva Luciana H, Ojopi Elida B

Abstract excerpt

OBJECTIVE: Epidermal growth factor receptor is involved in the pathogenesis of non-small cell lung cancer and has recently emerged as an important target for molecular therapeutics. The KRAS oncogene also plays an important role in the development of lung cancer. The aim of this study was to evaluate the frequency of epidermal growth factor receptor and KRAS mutations in a population of Brazilian patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Brazil
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Smoking

Source

Open in PubMed Open full text

Identifiers

PMID: 22666783
DOI: 10.6061/clinics/2012(05)03
PMCID: PMC3351259

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.PMID 22666783Read ↗

Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: a retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer care centers in India.Semantic proximity Read ↗

EGFR and KRAS mutations in patients with adenocarcinoma of the lung.Semantic proximity Read ↗

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.Semantic proximity Read ↗

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the LungSemantic proximity Read ↗

Prevalence of Epidermal Growth Factor Receptor Mutations in Patients with Non-Small Cell Lung Cancer in Turkish Population.Semantic proximity Read ↗

Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.Semantic proximity Read ↗

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study.Semantic proximity Read ↗

Mutational Analysis of EGFR Mutations in Non-Small Cell Lung Carcinoma-An Indian Perspective of 212 Patients.Semantic proximity Read ↗

Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutationsSemantic proximity Read ↗

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.Semantic proximity Read ↗

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.